QQQ $ 610.29 $ -0.16 (-0.03 %)
DIA $ 469.10 $ 2.20 (0.47 %)
SPY $ 670.98 $ -0.01 (0 %)
TLT $ 91.99 $ 0.45 (0.49 %)
GLD $ 376.61 $ -25.91 (-6.43 %)
$ 12.49
-- x --
-- x --
-- - --
$ 5.90 - $ 12.51
0
na
798.9M
$ 1.94
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 12-10-2024 10-31-2024 10-Q
2 09-09-2024 07-31-2024 10-Q
3 07-02-2024 04-30-2024 10-K
4 04-24-2024 01-31-2024 10-Q
5 12-07-2023 10-31-2023 10-Q
6 09-07-2023 07-31-2023 10-Q
7 06-21-2023 04-30-2023 10-K
8 03-13-2023 01-31-2023 10-Q
9 12-06-2022 10-31-2022 10-Q
10 09-06-2022 07-31-2022 10-Q
11 06-29-2022 04-30-2022 10-K
12 03-08-2022 01-31-2022 10-Q
13 12-07-2021 10-31-2021 10-Q
14 09-08-2021 07-31-2021 10-Q
15 06-29-2021 04-30-2021 10-K
16 03-08-2021 01-31-2021 10-Q
17 12-02-2020 10-31-2020 10-Q
18 09-01-2020 07-31-2020 10-Q
19 06-30-2020 04-30-2020 10-K
20 03-10-2020 01-31-2020 10-Q
21 12-09-2019 10-31-2019 10-Q
22 09-05-2019 07-31-2019 10-Q
23 06-27-2019 04-30-2019 10-K
24 03-11-2019 01-31-2019 10-Q
25 12-10-2018 10-31-2018 10-Q
26 09-10-2018 07-31-2018 10-Q
27 07-16-2018 04-30-2018 10-K
28 03-12-2018 01-31-2018 10-Q
29 12-11-2017 10-31-2017 10-Q
30 09-11-2017 07-31-2017 10-Q
31 07-14-2017 04-30-2017 10-K
32 03-13-2017 01-31-2017 10-Q
33 12-12-2016 10-31-2016 10-Q
34 09-08-2016 07-31-2016 10-Q
35 07-14-2016 04-30-2016 10-K
36 03-09-2016 01-31-2016 10-Q
37 12-10-2015 10-31-2015 10-Q
38 09-09-2015 07-31-2015 10-Q
39 07-14-2015 04-30-2015 10-K
40 03-12-2015 01-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 avid-bioservices-q2-eps-027-misses-012-estimate-sales-3350m-miss-3380m-estimate

Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(...

 rbc-capital-downgrades-avid-bioservices-to-sector-perform-raises-price-target-to-125

RBC Capital analyst Sean Dodge downgrades Avid Bioservices (NASDAQ:CDMO) from Outperform to Sector Perform and raises the pr...

 william-blair-reiterates-market-perform-on-avid-bioservices

William Blair analyst Max Smock reiterates Avid Bioservices (NASDAQ:CDMO) with a Market Perform.

 avid-bioservices-agrees-to-be-acquired-by-gho-capital-partners-and-ampersand-in-11b-transaction-shareholders-to-receive--1250-per-share-in-cash

The per share purchase price represents a 13.8% premium to Avid's closing share price of $10.98 on November 6, 2024, the la...

 rbc-capital-maintains-outperform-on-avid-bioservices-raises-price-target-to-12

RBC Capital analyst Sean Dodge maintains Avid Bioservices (NASDAQ:CDMO) with a Outperform and raises the price target from $...

 stephens--co-reiterates-overweight-on-avid-bioservices-maintains-12-price-target

Stephens & Co. analyst Jacob Johnson reiterates Avid Bioservices (NASDAQ:CDMO) with a Overweight and maintains $12 price...

 william-blair-reiterates-market-perform-on-avid-bioservices

William Blair analyst Max Smock reiterates Avid Bioservices (NASDAQ:CDMO) with a Market Perform.

 avid-bioservices-q1-2025-adj-eps-003-beats-006-estimate-sales-4017m-miss-4076m-estimate

Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0....

 why-avid-bioservices-stock-is-moving-higher-wednesday

Avid reported fourth quarter financial results on Tuesday after the market closed. The company reported a loss of $1.94 per sha...

 rbc-capital-reiterates-outperform-on-avid-bioservices-maintains-8-price-target

RBC Capital analyst Sean Dodge reiterates Avid Bioservices (NASDAQ:CDMO) with a Outperform and maintains $8 price target.

 avid-bioservices-q4-2024-gaap-eps-194-vs-004-estimate-sales-43000m-beat-42142m-estimate

Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(1.94) per share which missed the analyst consensus estimate of $(...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION